Nosocomial infections, or healthcare-associated infections, affect 1 in 10 patients worldwide, according to WHO data. In Europe alone, the number of cases exceeds 4.3 million annually. These infections, occurring during medical care, impact not only patients but also healthcare professionals, primarily transmitted through airborne routes and aerosols in clinical environments.
Studies and real hospital cases have shown that advanced respiratory protection can significantly reduce infection rates, particularly in aerosol exposure scenarios.
Bidirectional protection
Clyype's solution, a tubeless respiratory protection device, offers 99.8% bidirectional filtration, surpassing FFP3 standards. This feature protects both the user and the environment, preventing cross-contamination in hospital settings where aerosols are a common transmission route.
Our tubeless design eliminates movement restrictions and pressure points, especially in healthcare roles where protection use extends for hours.
The screen facilitates communication and facial visibility for interaction with patients and multidisciplinary teams. Additionally, the device is compatible with glasses and contact lenses, making it a practical solution for daily use in hospital environments.
Nosocomial infections remain a global challenge for healthcare systems. Advanced respiratory protection like Clyype's demonstrates that risk reduction is possible in contexts
